<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://dermfield.com/articles/ccl21-icam1-niche-accelerates-ot-i-t-cell-hits-against-b16-melanoma-6373e67a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T20:25:02.722Z</news:publication_date>
      <news:title>CCL21-ICAM1 niche accelerates OT-I T-cell hits against B16 melanoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/recognizing-skin-conditions-in-children-with-darker-skin-tones-7d0cf540</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T19:55:02.705Z</news:publication_date>
      <news:title>Recognizing Skin Conditions in Children With Darker Skin Tones</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/atopic-dermitis-leaves-marks-on-education-and-career-paths-study-finds-0c903f53</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T19:55:02.705Z</news:publication_date>
      <news:title>Atopic Dermitis Leaves Marks on Education and Career Paths, Study Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/international-panel-reaches-consensus-on-tapering-psoriasis-biologics-2157b816</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T19:55:02.705Z</news:publication_date>
      <news:title>International Panel Reaches Consensus on Tapering Psoriasis Biologics</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/sun-pharma-s-unloxcyt-earns-nccn-category-2a-status-for-advanced-skin-cancer-79646ef5</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T19:25:02.676Z</news:publication_date>
      <news:title>Sun Pharma&apos;s Unloxcyt Earns NCCN Category 2A Status for Advanced Skin Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/oral-psoriasis-therapy-icotyde-sustains-response-at-two-years-1fa1923d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T18:25:02.608Z</news:publication_date>
      <news:title>Oral Psoriasis Therapy ICOTYDE Sustains Response at Two Years</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jak-inhibitors-for-alopecia-areata-counseling-and-agent-choice-667d7f08</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:55:02.578Z</news:publication_date>
      <news:title>JAK Inhibitors for Alopecia Areata: Counseling and Agent Choice</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/aad-and-hs-foundation-release-first-joint-hidradenitis-suppurativa-guidelines-20ca39c6</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:55:02.578Z</news:publication_date>
      <news:title>AAD and HS Foundation Release First Joint Hidradenitis Suppurativa Guidelines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jak-inhibitors-for-alopecia-areata-selectivity-meets-pivotal-trial-efficacy-58332251</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:25:02.555Z</news:publication_date>
      <news:title>JAK Inhibitors for Alopecia Areata: Selectivity Meets Pivotal Trial Efficacy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dupixent-lawsuit-filed-after-mycosis-fungoides-diagnosis-eb842f5d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:20:02.552Z</news:publication_date>
      <news:title>Dupixent Lawsuit Filed After Mycosis Fungoides Diagnosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/skin-longevity-demands-evidence-not-marketing-hype-644be6ed</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:50:02.516Z</news:publication_date>
      <news:title>Skin Longevity Demands Evidence, Not Marketing Hype</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/flare-program-targets-sun-protection-in-melanoma-risk-children-74e03177</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:50:02.516Z</news:publication_date>
      <news:title>FLARE Program Targets Sun Protection in Melanoma-Risk Children</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/melatonin-slows-skin-cell-aging-by-quieting-cxcl9-inflammation-9ddac83a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:30:02.506Z</news:publication_date>
      <news:title>Melatonin Slows Skin Cell Aging by Quieting CXCL9 Inflammation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/cd300f-identified-as-inducible-brake-on-mast-cell-activation-ab31ade5</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:30:02.506Z</news:publication_date>
      <news:title>CD300f Identified as Inducible Brake on Mast Cell Activation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/us-cutaneous-t-cell-lymphoma-incidence-falls-catching-researchers-off-guard-275401a8</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:20:02.500Z</news:publication_date>
      <news:title>US Cutaneous T-Cell Lymphoma Incidence Falls, Catching Researchers Off Guard</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/aad-and-hs-foundation-issue-first-joint-hidradenitis-suppurativa-guidelines-a848ceb9</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:20:02.500Z</news:publication_date>
      <news:title>AAD and HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/yale-medicine-turns-skin-biology-into-smarter-skin-care-47c5100f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T16:20:02.500Z</news:publication_date>
      <news:title>Yale Medicine Turns Skin Biology Into Smarter Skin Care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/aad-and-hs-foundation-issue-first-joint-hidradenitis-suppurativa-guidelines-fe7b03a3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T15:50:02.486Z</news:publication_date>
      <news:title>AAD and HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/sente-s-heparan-sulfate-plus-vitamin-c-pairing-clears-peer-review-9726ebe2</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T15:50:02.486Z</news:publication_date>
      <news:title>Senté&apos;s Heparan Sulfate plus Vitamin C Pairing Clears Peer Review</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/melanoma-prevention-in-children-a-new-prevention-approach-emerges-3793cd92</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T14:50:02.439Z</news:publication_date>
      <news:title>Melanoma Prevention in Children: A New Prevention Approach Emerges</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/3d-skin-models-offer-new-window-into-microbiome-of-chronic-wounds-67581769</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T14:50:02.439Z</news:publication_date>
      <news:title>3D Skin Models Offer New Window Into Microbiome of Chronic Wounds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/physicians-in-136-countries-link-climate-shifts-to-skin-findings-a95ecf85</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T14:20:02.424Z</news:publication_date>
      <news:title>Physicians in 136 Countries Link Climate Shifts to Skin Findings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/nccn-grants-unloxcyt-category-2a-preferred-status-in-advanced-skin-cancer-5198487f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T14:20:02.424Z</news:publication_date>
      <news:title>NCCN Grants UNLOXCYT Category 2A Preferred Status in Advanced Skin Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/real-world-data-probe-infection-risk-in-systemic-psoriasis-therapy-01c83711</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T13:50:02.411Z</news:publication_date>
      <news:title>Real-World Data Probe Infection Risk in Systemic Psoriasis Therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-publishes-first-derm-care-recommendations-for-pten-syndrome-9dfdcf54</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T13:25:02.386Z</news:publication_date>
      <news:title>JAAD Publishes First Derm Care Recommendations for PTEN Syndrome</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/health-canada-approves-skyrizi-for-pediatric-plaque-psoriasis-2877477c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T13:20:02.385Z</news:publication_date>
      <news:title>Health Canada Approves Skyrizi for Pediatric Plaque Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/glp-1-access-and-hidradenitis-suppurativa-trials-what-s-moving-5231622d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T13:20:02.385Z</news:publication_date>
      <news:title>GLP-1 Access and Hidradenitis Suppurativa Trials: What&apos;s Moving</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/solabia-divests-diagnostics-bets-fully-on-cosmetic-actives-30b1937a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T12:55:02.370Z</news:publication_date>
      <news:title>Solabia Divests Diagnostics, Bets Fully on Cosmetic Actives</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/emerging-oral-therapies-take-aim-at-hs-inflammation-9a89b2a8</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T12:20:02.344Z</news:publication_date>
      <news:title>Emerging Oral Therapies Take Aim at HS Inflammation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/emerging-oral-hs-agents-new-efficacy-and-safety-data-5e25e709</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T12:15:02.334Z</news:publication_date>
      <news:title>Emerging Oral HS Agents: New Efficacy and Safety Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/chronic-hand-eczema-hitting-nhs-staff-report-finds-b3927497</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:45:02.319Z</news:publication_date>
      <news:title>Chronic Hand Eczema Hitting NHS Staff, Report Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/pgdx-elio-tissue-complete-cdx-lands-fda-clearance-for-melanoma-braf-testing-aa285e5b</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:45:02.319Z</news:publication_date>
      <news:title>PGDx elio tissue complete CDx lands FDA clearance for melanoma BRAF testing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/rare-severe-gardner-diamond-syndrome-like-neutrophil-report-db76534e</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:25:02.302Z</news:publication_date>
      <news:title>Rare Severe Gardner-Diamond Syndrome-Like Neutrophil Report</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-pilot-pits-intralesional-ala-pdt-against-topical-pdt-with-co2-laser-ee8b8853</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:25:02.302Z</news:publication_date>
      <news:title>JAAD Pilot Pits Intralesional ALA-PDT Against Topical PDT With CO2 Laser</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/glp-1-medicolegal-exposure-under-review-in-jaad-november-issue-72d44259</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:25:02.302Z</news:publication_date>
      <news:title>GLP-1 medicolegal exposure under review in JAAD November issue</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-paper-reconsiders-occipital-scalp-in-advanced-hair-loss-1ebafe61</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:20:02.381Z</news:publication_date>
      <news:title>JAAD Paper Reconsiders Occipital Scalp in Advanced Hair Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-comment-sets-biopsy-geometry-rules-for-acral-lesions-776eac17</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Comment Sets Biopsy Geometry Rules for Acral Lesions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-psychodermatology-paper-covers-u-s-court-cases-from-19142025-ece49c13</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD psychodermatology paper covers U.S. court cases from 1914–2025</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-asks-how-much-of-a-biologic-s-power-is-the-drug-itself-f478dd21</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Study Asks: How Much of a Biologic&apos;s Power Is the Drug Itself?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-publishes-multicenter-series-on-checkpoint-inhibitor-eosinophilic-fasciitis-632da05a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Publishes Multicenter Series on Checkpoint-Inhibitor Eosinophilic Fasciitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/adjuvant-radiation-shows-no-survival-gain-in-low-risk-merkel-cell-carcinoma-d76ae01f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Adjuvant Radiation Shows No Survival Gain in Low-Risk Merkel Cell Carcinoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/parallel-polarized-dermoscopy-under-study-for-acral-pattern-analysis-382380b7</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Parallel-Polarized Dermoscopy Under Study for Acral Pattern Analysis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-flags-emerging-sexually-transmissible-pathogens-beyond-classic-stis-e2c6e99f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD flags emerging sexually transmissible pathogens beyond classic STIs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-calls-for-transparent-reporting-as-ai-enters-evidence-synthesis-a78a503c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Calls for Transparent Reporting as AI Enters Evidence Synthesis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/rosacea-interventions-compared-across-phenotype-relevant-outcomes-1abec132</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Rosacea interventions compared across phenotype-relevant outcomes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-asks-can-intralesional-5-fu-intervals-stretch-in-low-risk-scc-0e80f91b</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Study Asks: Can Intralesional 5-FU Intervals Stretch in Low-Risk SCC?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-ethics-review-targets-coordinated-interview-releases-6ec2440a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Ethics Review Targets Coordinated Interview Releases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/trial-design-and-radiographic-outcomes-in-psa-il-23-trials-c1c45b0b</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Trial design and radiographic outcomes in PsA IL-23 trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/hsdd-in-menopausal-women-dermatology-meets-hormone-therapy-1e5f0ede</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>HSDD in Menopausal Women: Dermatology Meets Hormone Therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/330-patient-cohort-tracks-baricitinib-long-term-in-alopecia-areata-9d9ffa8f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>330-Patient Cohort Tracks Baricitinib Long-Term in Alopecia Areata</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-examines-disparities-in-infantile-hemangioma-care-380dc5f6</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD study examines disparities in infantile hemangioma care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-article-raises-refill-ethics-in-asynchronous-teledermatology-ea62f86c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD article raises refill ethics in asynchronous teledermatology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-comment-puts-isotretinoinantidepressant-suicide-signals-under-the-lens-b97087e1</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Comment Puts Isotretinoin–Antidepressant Suicide Signals Under the Lens</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-probes-direct-immunofluorescence-in-oral-esophageal-lichen-planus-32a7e309</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD study probes direct immunofluorescence in oral, esophageal lichen planus</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/pregnancy-privacy-procedural-risk-jaad-sets-nov-2026-review-8aa9eb84</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Pregnancy, Privacy, Procedural Risk: JAAD Sets Nov 2026 Review</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-article-tackles-ethics-for-immunosuppressed-patients-f513f4db</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Article Tackles Ethics for Immunosuppressed Patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dupilumab-holds-up-over-52-weeks-in-prurigo-nodules-9e95e741</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Dupilumab Holds Up Over 52 Weeks in Prurigo Nodules</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/monobenzone-depigmentation-what-drives-patient-satisfaction-in-vitiligo-385e93c8</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Monobenzone depigmentation: what drives patient satisfaction in vitiligo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-tracks-racial-differences-in-frontal-fibrosing-alopecia-c09b55df</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD study tracks racial differences in frontal fibrosing alopecia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/nie-and-colleagues-answer-critics-of-isotretinoin-suicidality-study-e07cf42e</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Nie and colleagues answer critics of isotretinoin suicidality study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/trinetx-study-maps-hiv-linked-skin-disease-across-us-racial-groups-ba66dc97</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>TriNetX Study Maps HIV-Linked Skin Disease Across US Racial Groups</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-weighs-photodynamic-therapy-for-onychomycosis-evidence-e4ddcab4</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Weighs Photodynamic Therapy for Onychomycosis Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-publishes-reply-on-tofacitinib-and-skin-sclerosis-data-ec59af67</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Publishes Reply on Tofacitinib and Skin Sclerosis Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-examines-biologic-safety-in-psoriasis-patients-with-malignancy-421e37d2</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Study Examines Biologic Safety in Psoriasis Patients With Malignancy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-comment-addresses-487-gene-atopic-dermatitis-trial-af29ed62</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Comment Addresses 487-Gene Atopic Dermatitis Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-pilot-pits-mometasone-against-crisaborole-and-tofacitinib-a25d71f8</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Pilot Pits Mometasone Against Crisaborole and Tofacitinib</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-meta-analysis-weighs-pneumocystis-prophylaxis-in-rituximab-patients-aea42ba9</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD meta-analysis weighs Pneumocystis prophylaxis in rituximab patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/elston-responds-on-ai-evidence-synthesis-and-transparency-a1b4c545</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Elston responds on AI evidence synthesis and transparency</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/bambusa-therapeutics-details-bbt001-atopic-dermatitis-data-at-isad-2026-ac1459d7</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Bambusa Therapeutics Details BBT001 Atopic Dermatitis Data at ISAD 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-images-focus-on-autoimmune-bullous-disorders-in-skin-of-color-e21a8ac2</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Images Focus on Autoimmune Bullous Disorders in Skin of Color</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/palmoplantar-pustulosis-burden-exceeds-psoriasis-alone-danish-cohort-finds-ec89d172</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>Palmoplantar Pustulosis Burden Exceeds Psoriasis Alone, Danish Cohort Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-commentary-frames-acupuncture-in-urticaria-as-an-ethics-question-70d195a8</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD commentary frames acupuncture in urticaria as an ethics question</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-lines-up-a-november-2026-paper-on-biologic-requests-and-social-media-da062a41</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:15:02.287Z</news:publication_date>
      <news:title>JAAD Lines Up a November 2026 Paper on Biologic Requests and Social Media</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/trinity-college-dublin-team-reports-new-medicine-for-atopic-dermatitis-dec87801</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T08:40:02.178Z</news:publication_date>
      <news:title>Trinity College Dublin Team Reports New Medicine for Atopic Dermatitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/merck-and-moderna-to-file-personalized-mrna-melanoma-vaccine-with-fda-51add874</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T06:40:02.096Z</news:publication_date>
      <news:title>Merck and Moderna to File Personalized mRNA Melanoma Vaccine With FDA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/anifrolumab-tied-to-lower-infection-and-hospitalization-risk-in-skin-lupus-ef790a31</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T05:40:02.057Z</news:publication_date>
      <news:title>Anifrolumab Tied to Lower Infection and Hospitalization Risk in Skin Lupus</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/next-generation-tyk2-inhibitors-what-could-they-add-to-psoriasis-care-06e7a8be</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T05:10:02.037Z</news:publication_date>
      <news:title>Next-generation TYK2 Inhibitors: What Could They Add to Psoriasis Care?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/glp-1-candidacy-and-prescribing-considerations-in-psoriasis-07259e07</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T23:40:01.624Z</news:publication_date>
      <news:title>GLP-1 Candidacy and Prescribing Considerations in Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/machine-learning-ties-facial-microbes-to-skin-quality-in-korean-women-96f33ff6</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T23:10:01.562Z</news:publication_date>
      <news:title>Machine Learning Ties Facial Microbes to Skin Quality in Korean Women</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/esmo-2026-preview-which-melanoma-results-could-shift-practice-e4b2326f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T22:10:01.481Z</news:publication_date>
      <news:title>ESMO 2026 Preview: Which Melanoma Results Could Shift Practice?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/litifilimab-improves-skin-disease-activity-in-phase-2-cle-trial-562c49da</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T21:40:01.464Z</news:publication_date>
      <news:title>Litifilimab Improves Skin Disease Activity in Phase 2 CLE Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/five-year-adlong-data-on-lebrikizumab-for-atopic-dermatitis-presented-95723eab</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T21:10:01.421Z</news:publication_date>
      <news:title>Five-Year ADlong Data on Lebrikizumab for Atopic Dermatitis Presented</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/cape-coral-melanoma-survivor-speaks-out-as-new-study-flags-deadly-skin-cancer-ri-be06206d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T21:10:01.421Z</news:publication_date>
      <news:title>Cape Coral Melanoma Survivor Speaks Out as New Study Flags Deadly Skin Cancer Risk for Floridians</news:title>
    </news:news>
  </url>
</urlset>
